Back

Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome

European Heart Journal - Cardiovascular Pharmacotherapy

20 April 2023
Organised by: Logo
Read full article
ESC Journals

Contributors

Mattia Galli
Mattia Galli

Author

Sapienza University of Rome Rome , Italy

Giuseppe Gargiulo
Giuseppe Gargiulo

Author

Federico II University Hospital Napoly , Italy

Stefano Benenati
Stefano Benenati

Author

Roxana Mehran
Roxana Mehran

Author

Dominick J Angiolillo
Dominick J Angiolillo

Author

You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Mortality with bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome
28 August 2023
thumbnail
Congress Presentation
Anticoagulation management of heartware left ventricular assist device thrombosis: comparison of heparin and bivalirudin
3 September 2019
thumbnail
Congress Presentation
Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial
20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources